Conversion from tacrolimus to belatacept improves renal function in kidney transplant patients with chronic vascular lesions in allograft biopsy

BACKGROUND: Conversion from tacrolimus to belatacept has been shown to be beneficial for an increasing number of kidney transplant (KT) patients. Predicting factors for favorable outcomes are still unknown. We aimed to investigate whether histological vascular lesions at the time of conversion might...

Descripción completa

Detalles Bibliográficos
Autores principales: Pérez-Sáez, María José, Yu, Bryant, Uffing, Audrey, Murakami, Naoka, Borges, Thiago J, Azzi, Jamil, El Haji, Sandra, Gabardi, Steve, Riella, Leonardo V
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Transplant Immune Suppression
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6671390/
https://www.ncbi.nlm.nih.gov/pubmed/31384452
http://dx.doi.org/10.1093/ckj/sfy115

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6671390/
https://www.ncbi.nlm.nih.gov/pubmed/31384452
http://dx.doi.org/10.1093/ckj/sfy115

Ejemplares similares